These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 25739142)

  • 1. Medical risk assessment algorithm for invasive dental care in patients with HIV disease.
    Fatahzadeh M
    J N J Dent Assoc; 2014; 85(4):20-5. PubMed ID: 25739142
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgical crown lengthening in a population with human immunodeficiency virus: a retrospective analysis).
    Kolhatkar S; Mason SA; Janic A; Bhola M; Haque S; Winkler JR
    J Periodontol; 2012 Mar; 83(3):344-53. PubMed ID: 21780902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral complication risks after invasive and non-invasive dental procedures in HIV-positive patients.
    Campo J; Cano J; del Romero J; Hernando V; Rodríguez C; Bascones A
    Oral Dis; 2007 Jan; 13(1):110-6. PubMed ID: 17241440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental extractions performed in HIV-positive patients.
    Diz Dios P; Vázquez García E; Feijoó JF
    J Dent Res; 1998 Apr; 77(4):533-4. PubMed ID: 9539454
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk Factors for Post-Tooth Extraction Complications in HIV-Infected Patients: a Retrospective Study.
    Nakagawa Y; Shimada Y; Kawasaki Y; Honda H; Aoki T; Takanabe Y; Takagi R; Maruoka Y; Oka S
    Jpn J Infect Dis; 2021 Sep; 74(5):392-398. PubMed ID: 33518617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What the dentist should know about a patient with HIV/AIDS.
    Lyles AM
    J Calif Dent Assoc; 2001 Feb; 29(2):158-69. PubMed ID: 11324117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.
    Torti C; Barnes E; Quiros-Roldan E; Puoti M; Carosi G; Klenerman P
    Antivir Ther; 2004 Feb; 9(1):139-42. PubMed ID: 15040546
    [No Abstract]   [Full Text] [Related]  

  • 8. The differences between providing oral health care to HIV-infected children and HIV-infected adults: a general dentist's guide.
    Gonzales CB; Smith S; Galvan A; Mabry J
    Gen Dent; 2010; 58(5):424-32; quiz 733-4. PubMed ID: 20829168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When CD4-cell count is nearly as undetectable as the viral load.
    Boyle BA; Gandhi RT
    AIDS Clin Care; 2004 Jun; 16(6):48-9. PubMed ID: 15241849
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of mixed cryoglobulins in relation to CD4 cell count among patients coinfected with HIV and hepatitis C virus.
    Aaron L; Lebray P; Alyanakian MA; Roudière L; Therby A; Chaix ML; Dupont B; Pol S; Viard JP
    Clin Infect Dis; 2005 Jan; 40(2):306-8. PubMed ID: 15655752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
    Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection and tooth loss.
    Engeland CG; Jang P; Alves M; Marucha PT; Califano J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):321-6. PubMed ID: 18280966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dental management prior to hematopoietic stem cell transplantation.
    Morimoto Y; Niwa H; Imai Y; Kirita T
    Spec Care Dentist; 2004; 24(6):287-92. PubMed ID: 15686278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dentistry and CD4+ cell counts.
    Glick M
    Penn Dent J (Phila); 1995; 94(1-2):8-9. PubMed ID: 15503430
    [No Abstract]   [Full Text] [Related]  

  • 15. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
    de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
    J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV].
    Gavazzi G; Richallet G; Morand P; Bouchard O; Bosseray A; Leclercq P; Micoud M
    Pathol Biol (Paris); 1998 Jun; 46(6):412-5. PubMed ID: 9769871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/HCV coinfection exacerbates ESLD risk.
    Highleyman L
    IAPAC Mon; 2006 Sep; 12(9):329. PubMed ID: 17378068
    [No Abstract]   [Full Text] [Related]  

  • 18. Current oral manifestations of HIV infection.
    Navazesh M
    J Calif Dent Assoc; 2001 Feb; 29(2):137-41. PubMed ID: 11324113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on hepatitis. HIV/HCV coinfection and ART.
    Carter M
    IAPAC Mon; 2006 May; 12(5):157. PubMed ID: 17249142
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the possible influence of hepatitis C virus and liver fibrosis on HIV type 1 immunological and virological outcomes.
    Collazos J; Cartón JA; Asensi V
    HIV Med; 2011 May; 12(5):308-15. PubMed ID: 20946441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.